The French giant Sanofi will invest two billion euros within five years in research and development on messenger RNA, to take the turn of this innovative technology at the origin of the first vaccines against Covid-19.
Read also: Covid-19: Sanofi increases its efforts in vaccine production
The laboratory announced Tuesday that it would devote 400 million euros per year by 2025 in research on new messenger RNA vaccines, investments which should continue beyond this period.